Hiral A. Kotak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiral A. Kotak has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Cally Jo Elizabeth Haynes
University College London
2 shared publications - Alvaro Keskküla
University College London
1 shared publication Anne Cheasty
Cancer Research Horizons, 2 Redman Place, London, E20 1JQ, UK
1 shared publicationCharlotte Bennett
Cancer Research Horizons, 2 Redman Place, London, E20 1JQ, UK
1 shared publicationCharlotte K. Hind
Research and Evaluation, Porton Down, UKHSA, Porton Down, Salisbury SP4 0JG, UK
1 shared publication- Duy Nguyen
University College London
1 shared publication
Latest Publications
- Open Access
- 30 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
High-throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time-consuming and resource-intensive, hindering the screening of large compound libraries. In this work we have developed an automated high-throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl-/NO3- antiport method, has been optimised for multi-well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- 30 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessHigh-throughput and Automated Anion Transport Assays
Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time-consuming and resource-intensive, hindering the screening of large compound libraries. In this work we have developed an automated high-throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl-/NO3- antiport method, has been optimised for multi-well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.
- Open Access
- 10 August 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (33) , 9761-9773
Establishing the selective phospholipid membrane coordination, permeation and lysis properties for a series of ‘druggable’ supramolecular self-associating antimicrobial amphiphiles
The rise of antimicrobial resistance remains one of the greatest global health threats facing humanity. Furthermore, the development of novel antibiotics has all but ground to a halt due to a collision of intersectional pressures. Herein we determine the antimicrobial efficacy for 14 structurally related supramolecular self-associating amphiphiles against clinically relevant Gram-positive methicillin resistant Staphylococcus aureus and Gram-negative Escherichia coli. We establish the ability of these agents to selectively target phospholipid membranes of differing compositions, through a combination of computational host:guest complex formation simulations, synthetic vesicle lysis, adhesion and membrane fluidity experiments, alongside our novel 1H NMR CPMG nanodisc coordination assays, to verify a potential mode of action for this class of compounds and enable the production of evermore effective next-generation antimicrobial agents. Finally, we select a 7-compound subset, showing two lead compounds to exhibit ‘druggable’ profiles through completion of a variety of in vivo and in vitro DMPK studies.
- 10 August 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (33) , 9761-9773
Open AccessEstablishing the selective phospholipid membrane coordination, permeation and lysis properties for a series of ‘druggable’ supramolecular self-associating antimicrobial amphiphiles
The rise of antimicrobial resistance remains one of the greatest global health threats facing humanity. Furthermore, the development of novel antibiotics has all but ground to a halt due to a collision of intersectional pressures. Herein we determine the antimicrobial efficacy for 14 structurally related supramolecular self-associating amphiphiles against clinically relevant Gram-positive methicillin resistant Staphylococcus aureus and Gram-negative Escherichia coli. We establish the ability of these agents to selectively target phospholipid membranes of differing compositions, through a combination of computational host:guest complex formation simulations, synthetic vesicle lysis, adhesion and membrane fluidity experiments, alongside our novel 1H NMR CPMG nanodisc coordination assays, to verify a potential mode of action for this class of compounds and enable the production of evermore effective next-generation antimicrobial agents. Finally, we select a 7-compound subset, showing two lead compounds to exhibit ‘druggable’ profiles through completion of a variety of in vivo and in vitro DMPK studies.